White Case Advises Langer Laumann on Acquisition of Majority Stakes in CPM and NDC Pokmon Card Market Surges Nostalgia Speculation and Celebrity Influence Drive MillionDollar Sales Traders Raise Bets on Federal Reserve Rate Hike by July 2027 Inheriting a Parents 401k Understanding the 25 IRS Penalty Risk for NonCompliance Crude Oil Futures Maintain Positive Bias as Rally Potential Emerges Trump Signals No Rush on Iran Deal Maintains Naval Blockade as Critics Face Scrutiny Corvex Inc MOVE Q1 2026 Earnings EPS Beat Boosts Shares as Loss Narrows Flowserve Q1 2026 Earnings EPS Beat Drives Modest Share Gains as Management Highlights Operational Execution HURN Q1 2026 Earnings EPS Beats Estimates as Consulting Services Maintain Momentum MNST Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Profitability Curbline Properties CURB Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds FNF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Real Estate Environment Gold Resource Corporation GORO Holds Steady at 129 Amid Consolidation NioCorp Developments Ltd Warrant NIOBW Surges 117 Testing Key Resistance at 201 Mitek Systems Edges Lower as Stock Tests Key Support Levels BioLife Solutions BLFS Rises Nearly 2 as Shares Test Key Resistance at 2573 MHNC Edges Lower as FixedIncome Security Faces Yield Pressure MRK Q1 2026 Earnings EPS Beats Estimates Despite Net Loss Shares Rise BDCI Q1 2026 Earnings Modest Profit Reported Amid Limited Revenue Disclosure Erdoan Visits Astana as Turkey and Kazakhstan Target 13 Billion in Bilateral Trade The Late Show With Stephen Colbert Finale Signals Shift in LateNight Television Landscape China Calls for APEC Cooperation as Commerce Minister Skips Opening Due to Urgent Business Sylvamo Corporation SLVM Q1 2026 Earnings Significant EPS Miss Amid Challenging Market Conditions Global Equity Funds Record First Weekly Outflow in Nine Weeks Amid Rising Inflation and Bond Yield Surge Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares NervGen Pharma NGEN Dips 282 to 207 Approaching Key Support